Patients' experiences of completing treatment for colorectal cancer in a Scottish District General Hospital

European Journal of Cancer Care
M F Simpson, F Whyte

Abstract

A review of the cancer literature from 1990 to 2003 indicated that some patients with cancer felt abandoned by healthcare professionals upon completion of treatment. With this in mind, a small qualitative study was undertaken to explore the experiences of patients completing treatment for colorectal cancer within a Scottish District General Hospital. A small purposeful sample of eight participants (surgery only n = 4 and surgery with adjuvant chemotherapy n = 4) who had completed treatment were recruited. Semi-structured interviews, in a venue chosen by the participants (home n = 7; hospital n = 1), were tape-recorded and transcribed verbatim. The mean time since completion of treatment was 30 weeks (range 9-95 weeks). Transcripts were read and reread several times to identify categories. By thematic analysis, five categories were identified: physical impact of treatment, completion of treatment, support of family and friends, impact of healthcare professionals and coping mechanisms. Despite the significant physical impact of treatment patients returned to their previous lifestyles and status. Although very optimistic and positive when treatment was completed, participants reflected upon their cancer recurring. Family and frien...Continue Reading

References

Dec 1, 1991·Nurse Education Today·P Burnard
Apr 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C A SchagJ J Lee
Feb 1, 1996·Cancer Nursing·S Halldorsdottir, E Hamrin
Jan 1, 1997·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D K Whynes, A R Neilson
Mar 1, 1997·Journal of Psychosomatic Research·M J BekkersG P van Berge Henegouwen
Jul 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J Norum
Oct 10, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·K UlanderG Grahn
Jul 28, 1999·Scandinavian Journal of Gastroenterology·B J KjeldsenO Kronborg
Mar 25, 2000·Cancer Practice·T B SahayM Fitch
Dec 12, 2001·The British Journal of Surgery·J Camilleri-Brennan, R J Steele
Mar 5, 2002·Nature Cell Biology
Apr 23, 2002·European Journal of Cancer Care·U OlssonI Bosaeus
Jul 10, 2003·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·E Lindop, S Cannon
Jul 10, 2003·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Alison Allen
Feb 26, 2004·European Journal of Cancer Care·G M LeydonM P Coleman

❮ Previous
Next ❯

Citations

Nov 8, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Susan BrowneUna Macleod
Jul 30, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Claire Taylor, Lindsey Morgan
Jun 30, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·K BeaverK Luker
Jan 26, 2010·International Journal of Nursing Studies·Claire TaylorSarah Cowley
Oct 10, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Barbara Worster, Susan Holmes
Oct 6, 2010·Journal of Clinical Nursing·Martina Cusack, Claire Taylor
Mar 16, 2012·European Journal of Cancer Care·C van MosselM E Purkis
Mar 20, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jenny DrottCarina Berterö
Aug 26, 2009·European Journal of Cancer Care·S J KingC Scott
May 23, 2015·Journal of Psychosocial Oncology·Pei Yi TanOw Yong Lai Meng
Nov 29, 2011·Clinical Journal of Oncology Nursing·Margaret LandersJoyce J Fitzpatrick
Jan 19, 2015·International Journal for Equity in Health·Louise MarryatPhilip Wilson
Mar 19, 2021·European Journal of Cancer Care·Chloe Yi Shing LimPhyllis Butow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.